ZYKADIA® (ceritinib) Co-Pay Assistance Program

Important Safety Information and Approved Use

ZYKADIA may cause serious side effects, such as:

Stomach and intestinal problems
ZYKADIA causes stomach and intestinal problems in most people, including diarrhea, nausea, vomiting, and stomach-area pain. These problems can sometimes be severe. Follow your health care provider’s instructions about taking medicines to help these symptoms. Call your health care provider for advice if your symptoms are severe or do not go away

Liver problems
ZYKADIA may cause liver injury. Your health care provider should do blood tests at least every month to check your liver during treatment with ZYKADIA. Tell your health care provider right away if you experience any of the following symptoms:
- You feel tired
- Your skin or the whites of your eyes turn yellow
- You have a decreased appetite
- Your urine turns dark or brown (tea color)
- You have itchy skin
- You have nausea or experience vomiting
- You have pain on the right side of your stomach area
- You bleed or bruise more easily than normal

Lung problems (pneumonitis)
ZYKADIA may cause severe or life-threatening swelling (inflammation) of the lungs during treatment that can lead to death. Symptoms may be similar to those symptoms from lung cancer. Tell your health care provider right away if you have any new or worsening symptoms, including:

Trouble breathing or shortness of breath
Cough, with or without mucous
Fever
Chest pain

Heart problems
ZYKADIA may cause very slow, very fast, or abnormal heartbeats. Your health care provider may check your heart during treatment with ZYKADIA. Tell your health care provider right away if you feel new chest pain or discomfort, dizziness or lightheadedness, faint, or have abnormal heartbeats. Tell your health care provider if you start to take or have any changes in heart or blood pressure medicines

High blood sugar (hyperglycemia)
People who have diabetes or glucose intolerance, or who take a corticosteroid medicine have an increased risk of high blood sugar with ZYKADIA. Your health care provider will check your blood sugar level before starting ZYKADIA and as needed during treatment with ZYKADIA. Call your health care provider right away if you have any symptoms of high blood sugar, including:

Increased thirst
Urinating often
Increased hunger
Blurred vision
Headaches
Tiredness
Trouble thinking or concentrating
Your breath smells like fruit

Inflammation of the pancreas (pancreatitis)
ZYKADIA can cause pancreatitis that has led to death. You may develop increased pancreatic enzyme blood levels, which may be a sign of pancreatitis. Signs and symptoms of pancreatitis include upper abdominal pain that may spread to the back and get worse with eating. Your health care provider should perform blood tests to check your pancreatic enzyme blood levels before you start ZYKADIA and as needed during your treatment

Before you take ZYKADIA, tell your health care provider about all of your medical conditions, including if you:

have liver problems
have diabetes or high blood sugar
have heart problems, including a condition called long QT syndrome
have or have had pancreatitis
are pregnant or plan to become pregnant. ZYKADIA can harm your unborn baby. Women who are able to become pregnant should use an effective method of birth control during treatment with ZYKADIA and for 6 months after stopping ZYKADIA. Talk to your health care provider about birth control methods that may be right for you. Tell your health care provider right away if you become pregnant or think that you may be pregnant

Men with female partners who are able to become pregnant should use condoms during treatment with ZYKADIA and for 3 months after stopping ZYKADIA

are breastfeeding or plan to breastfeed. It is not known if ZYKADIA passes into breast milk. Do not breastfeed during treatment with ZYKADIA and for 2 weeks after stopping ZYKADIA

Tell your health care provider about the medicines you take, including:

Prescription medicines
Vitamins
Over-the-counter medicines
Herbal supplements

The most common side effects of ZYKADIA include:

Diarrhea
Stomach-area pain
Weight loss
Nausea
Tiredness (fatigue)
Vomiting
Decreased appetite

Tell your health care provider if you have any side effect that bothers you or does not go away. These are not all of the possible side effects of ZYKADIA. For more information, ask your health care provider or pharmacist.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

How to take ZYKADIA and what to avoid

Take ZYKADIA exactly as your health care provider tells you. Do not change your dose or stop taking unless your health care provider tells you to
Take ZYKADIA 1 time each day
Take ZYKADIA at least 1 hour before or at least 2 hours after meals. If you vomit after taking ZYKADIA, do not take an additional dose, but continue with the next scheduled dose
If you miss a dose of ZYKADIA, take it as soon as you remember. If your next dose is due within 12 hours, skip the missed dose. Just take the next dose at your regular time
You should not drink grapefruit juice or eat grapefruit during treatment with ZYKADIA. It may make the amount of ZYKADIA in your blood increase to a harmful level

Please see the full Prescribing Information and the Patient Information for ZYKADIA^® (ceritinib) capsules.

Approved Use:

ZYKADIA^® (ceritinib) capsules is a prescription medicine that is used to treat people with non-small cell lung cancer (NSCLC) that:

Is caused by a defect in a gene called anaplastic lymphoma kinase (ALK) and has spread to other parts of the body

It is not known if ZYKADIA is safe and effective in children.

< Back To Site

Prescribing Info including Patient Info

Patient Support Line 1-888-669-6682 M-F 8:30 AM-5:00 PM ET

Important Safety Information:

ZYKADIA may cause serious side effects, such as:

Stomach and intestinal problems ZYKADIA causes stomach and intestinal problems in most people, including diarrhea, nausea, vomiting, and stomach-area pa...

Approved Use:

ZYKADIA^® (ceritinib) capsules is a prescription medicine that is used to treat people with non-small cell lung cancer (NSCLC) that:

Is caused by a defect in a gene called anaplastic lymphoma kinase (ALK) and has spread to other parts of the body

It is not known if ZYKADIA is safe and effective in children.

Important Safety Information:

ZYKADIA may cause serious side effects, such as:

Stomach and intestinal problems
ZYKADIA causes stomach and intestinal problems in most people, including diarrhea, nausea, vomiting, and stomach-area pain. These problems can sometimes be severe. Follow your health care provider’s instructions about taking medicines to help these symptoms. Call your health care provider for advice if your symptoms are severe or do not go away

Liver problems
ZYKADIA may cause liver injury. Your health care provider should do blood tests at least every month to check your liver during treatment with ZYKADIA. Tell your health care provider right away if you experience any of the following symptoms:
- You feel tired
- Your skin or the whites of your eyes turn yellow
- You have a decreased appetite
- Your urine turns dark or brown (tea color)

You have itchy skin
You have nausea or experience vomiting
You have pain on the right side of your stomach area
You bleed or bruise more easily than normal

Lung problems (pneumonitis)
ZYKADIA may cause severe or life-threatening swelling (inflammation) of the lungs during treatment that can lead to death. Symptoms may be similar to those symptoms from lung cancer. Tell your health care provider right away if you have any new or worsening symptoms, including:

Trouble breathing or shortness of breath
Cough, with or without mucous

Fever
Chest pain

Heart problems
ZYKADIA may cause very slow, very fast, or abnormal heartbeats. Your health care provider may check your heart during treatment with ZYKADIA. Tell your health care provider right away if you feel new chest pain or discomfort, dizziness or lightheadedness, faint, or have abnormal heartbeats. Tell your health care provider if you start to take or have any changes in heart or blood pressure medicines

High blood sugar (hyperglycemia)
People who have diabetes or glucose intolerance, or who take a corticosteroid medicine have an increased risk of high blood sugar with ZYKADIA. Your health care provider will check your blood sugar level before starting ZYKADIA and as needed during treatment with ZYKADIA. Call your health care provider right away if you have any symptoms of high blood sugar, including:

Increased thirst
Urinating often

Increased hunger
Blurred vision

Headaches
Tiredness

Trouble thinking or concentrating
Your breath smells like fruit

Inflammation of the pancreas (pancreatitis)
ZYKADIA can cause pancreatitis that has led to death. You may develop increased pancreatic enzyme blood levels, which may be a sign of pancreatitis. Signs and symptoms of pancreatitis include upper abdominal pain that may spread to the back and get worse with eating. Your health care provider should perform blood tests to check your pancreatic enzyme blood levels before you start ZYKADIA and as needed during your treatment

Before you take ZYKADIA, tell your health care provider about all of your medical conditions, including if you:

have liver problems
have diabetes or high blood sugar
have heart problems, including a condition called long QT syndrome
have or have had pancreatitis
are pregnant or plan to become pregnant. ZYKADIA can harm your unborn baby. Women who are able to become pregnant should use an effective method of birth control during treatment with ZYKADIA and for 6 months after stopping ZYKADIA. Talk to your health care provider about birth control methods that may be right for you. Tell your health care provider right away if you become pregnant or think that you may be pregnant

Men with female partners who are able to become pregnant should use condoms during treatment with ZYKADIA and for 3 months after stopping ZYKADIA

are breastfeeding or plan to breastfeed. It is not known if ZYKADIA passes into breast milk. Do not breastfeed during treatment with ZYKADIA and for 2 weeks after stopping ZYKADIA

Tell your health care provider about the medicines you take, including:

Prescription medicines
Vitamins

Over-the-counter medicines
Herbal supplements

The most common side effects of ZYKADIA include:

Diarrhea
Stomach-area pain
Weight loss

Nausea
Tiredness (fatigue)

Vomiting
Decreased appetite

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

How to take ZYKADIA and what to avoid

Take ZYKADIA exactly as your health care provider tells you. Do not change your dose or stop taking unless your health care provider tells you to
Take ZYKADIA 1 time each day
Take ZYKADIA at least 1 hour before or at least 2 hours after meals. If you vomit after taking ZYKADIA, do not take an additional dose, but continue with the next scheduled dose
If you miss a dose of ZYKADIA, take it as soon as you remember. If your next dose is due within 12 hours, skip the missed dose. Just take the next dose at your regular time
You should not drink grapefruit juice or eat grapefruit during treatment with ZYKADIA. It may make the amount of ZYKADIA in your blood increase to a harmful level

Please see the full Prescribing Information and the Patient Information for ZYKADIA^® (ceritinib) capsules.

Approved Use:

ZYKADIA^® (ceritinib) capsules is a prescription medicine that is used to treat people with non-small cell lung cancer (NSCLC) that:

Is caused by a defect in a gene called anaplastic lymphoma kinase (ALK) and has spread to other parts of the body

It is not known if ZYKADIA is safe and effective in children.

Back To Site

About the Co-Pay Card

Novartis Oncology offers access to information about financial assistance for almost all Novartis Oncology products. You may be eligible for immediate co-pay savings on your next prescription:

Commercially insured patients pay $25 per month
Novartis will pay the remaining co-pay, up to $15,000 per calendar year

Limitations apply. Offer is not valid under Medicare, Medicaid, or any other federal or state program. Novartis reserves the right to rescind, revoke, or amend this program without notice. For full terms and conditions, visit www.CoPay.NovartisOncology.com or call 1-877-577-7756.

Click here to see if you are eligible, or call 1-877-577-7756.

See if you're eligible

Universal co-pay card

Patient Assistance Now Oncology

Novartis Oncology is committed to helping you get the medicines you need. Getting access to medications can sometimes be difficult or confusing. Patient Assistance Now Oncology (PANO) offers tools and support designed specifically to help make that process easier.

Support for patients includes:

Help you understand your insurance coverage and financial responsibilities through the insurance verification process
Help you identify/determine pharmacies covered by your plan
Provide insurance and Medicare education
Provide information about financial assistance that may be available
Patient Support Counselors who are able to provide information in over 160 languages
One single point of contact to help guide you through getting access to the medicine prescribed by your doctor

To learn more, call 1-800-282-7630

Next: Frequently Asked Questions

Financial Resources

ZYKADIA® (ceritinib)

About the Co-Pay Card

Patient Assistance Now Oncology

ZYKADIA^® (ceritinib)